MFOLFOXIRI Plus PD-1 Inhibitor Vs MFOLFOX6 As Neoadjuvant Therapy for Locally Advanced Colon Cancer

NCT06890624 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

138

Enrollment

OTHER

Sponsor class

Conditions

Colon Cancer (stage II &amp; III)

Interventions

DRUG: cmFOLFOXIRI plus PD-1 inhibitor
DRUG: mFOLFOX6

Sponsor

Sun Yat-sen University